The probably use of MR-spectroscopy and diffusion weighted-MRI of bone marrow for treatment monitoring in patients with chronic lymphatic leukemia

dc.contributor.authorMartínez de Vega, Vicente
dc.contributor.authorJiménez de la Peña, Mar
dc.contributor.authorCarrascoso, Javier
dc.contributor.authorRubio Alonso, Margarita
dc.contributor.authorBachiller, Juan
dc.contributor.authorMartínez Chamorro, Carmen
dc.contributor.authorRecio Rodríguez, Manuel
dc.date.accessioned2021-03-11T16:31:51Z
dc.date.available2021-03-11T16:31:51Z
dc.date.issued2021
dc.description.abstractObjectives: To assess the usefulness of proton MR-spectroscopy (1H-MRS) and diffusion-weighted MRI (DW-MRI) sequences in the follow-up of CLL-patients with chemotherapy treatment. The monitoring of CLL-patients susceptible to chemotherapy treatment is complicated due to the difficulty in assessing the response to treatment. Chemotherapy leads to changes in bone marrow composition and these changes can be evaluated by functional MR-sequences. Methods: 23 patients diagnosed with CLL by our hospital’s Hematology Service underwent a lumbar MR prior and post-chemotherapy applying 1H-MRS and DW-MRI. The concentrations of water and lipids were quantified applying the quantification program LCModel. The Apparent Diffusion Coefficient (ADC) values were calculated with the Functool program (GE). The Wilcoxon sign test was used to compare pre and post treatment results, considering statistically significant P values lower than 0.05. Results: Responder patients decreased the ratio H2O/lipids concentration measured with 1H-MRS and increased the ADC value on DW-MRI in post-treatment studies (P<0.05). Patients without response increased the ratio and decreased the ADC values or did not modify the data. Conclusion: 1H-MRS and DW-MRI of spinal bone marrow are non-invasive and repeatable techniques that might help in follow-up monitoring of patients with CLL.spa
dc.description.filiationUEMspa
dc.description.impactNo data 2021spa
dc.description.sponsorshipSin financiaciónspa
dc.identifier.citationMartínez-Vega, V., Jiménez-Pena, M., Carrascoso-Arranz, J., Rubio-Alonso, M., Bachiller-Egea, J., Martínez-Chamorro, C., & Recio-Rodríguez, M. (2021). The probably use of MR-spectroscopy and diffusion weighted-MRI of bone marrow for treatment monitoring in patients with chronic lymphatic leukemia. Annals of Bone Marrow Research, 6(1), 1–6. https://doi.org/10.17352/abmr.000007spa
dc.identifier.doi10.17352/abmr.000007
dc.identifier.issn2692-4684
dc.identifier.urihttp://hdl.handle.net/11268/9916
dc.language.isoengspa
dc.peerreviewedSispa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacionalspa
dc.rights.accessRightsopen accessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.subject.otherLeucemia linfoidespa
dc.subject.otherEspectroscopía de resonancia magnéticaspa
dc.subject.unescoCáncerspa
dc.subject.unescoTratamiento médicospa
dc.subject.unescoTecnología médicaspa
dc.titleThe probably use of MR-spectroscopy and diffusion weighted-MRI of bone marrow for treatment monitoring in patients with chronic lymphatic leukemiaspa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicationc151d669-9818-47b4-b683-19457fc8e162
relation.isAuthorOfPublication313d8108-0e33-4104-8bbf-7356387fcb75
relation.isAuthorOfPublication0413b5c5-4ebf-4116-b5d7-829f891a6e9c
relation.isAuthorOfPublication3d446e00-e2d3-4c59-837c-f6f25641e481
relation.isAuthorOfPublication.latestForDiscoveryc151d669-9818-47b4-b683-19457fc8e162

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Rubio_Alonso_ABM_2021.pdf
Size:
495.8 KB
Format:
Adobe Portable Document Format
Description:
Versión del editor